|
RLYB | Rallybio Corp |
|
|
RLYB | Rallybio Corp |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.11 |
| Leverage | 6.91% |
| Market Cap | $ 533.6m |
| PE | 0.00 |
| Dividend Yield | 1489376.78% |
| Profit | $ -9.0m |
| Margin | -38.38% |
None